Colleagues,
As reported in BioTech Transfer Week ... Maryland this week announced the recipients of $2.9 million in research funding through the inaugural Maryland Nanobiotechnology Research and Industry Competition grants program.
Under the program, project winners from the public and private sectors will receive awards of up to $250,000...
The 12 winning projects are:
• Aeras Global TB Vaccine Foundation, of Rockville; for "Targeted protein expression;"
• AparnaBio, of Rockville; for "Targeted anti-angiogenic siRNA nanoparticle to treat lung cancer;"
• Applied Sensor Research & Development Corporation, of Arnold; for "Acoustic array biosensor utilizing nanostructured films for multiplexed point-of-care diagnosis of infectious agents;"
• Bioactive Surgical, of Baltimore; for "High-density nanofilms for orthopedic therapies;"
• Cytimmune, of Rockville; for "Development and pilot manufacturing for a multifunctional tumor-targeting nanomedicine;"
• Johns Hopkins, for "Image-guided encapsulated cell therapy using multimodal nanoparticles;"
• Johns Hopkins, for "Functional characterization of a novel RNA helicase inhibitor encapsulated in duel-MR contrast nanoparticles for breast cancer treatment;"
• UM-Baltimore, for "Plasmon-controlled fluorescence and its application to fluorescence sensing;"
• UM-College Park, for "Advanced optical torque wrench for manipulation of DNA structures;"
• UM-College Park, for "Force-sensitive nano networks;"
• UM-College Park, for "Targeted drug delivery mediated nanocontainers;" and
• UM-College Park, for "A micro-direct methanol fuel cell with nanostructured platinum catalysts using the tobacco mosaic virus."
The Maryland Department of Business and Economic Development is funding the program and, through its recently formed Maryland Biotechnology Center, jointly administered the grant competition along with the Maryland Technology Development Corporation (TEDCO).
Read on at:
http://www.genomeweb.com//node/918070?emc=el&m=412799&l=6&a...
ENJOY!
CC